Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 197,420,670
- Total 13F shares
- 26,281,827
- Share change
- -1,384,525
- Total reported value
- $26,537,879
- Put/Call ratio
- 1.2%
- Price per share
- $1.01
- Number of holders
- 44
- Value change
- -$13,148,563
- Number of buys
- 25
- Number of sells
- 27
Report period
Q1 2020
Institutions
44
Top holders
10
ABUS full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
2.9%
|
5,666,754
|
$15,754,000 | — | 31 Dec 2019 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
1.9%
|
3,705,128
|
$10,300,000 | — | 31 Dec 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.5%
|
2,943,789
|
$8,184,000 | — | 31 Dec 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.96%
|
1,897,284
|
$5,274,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.95%
|
1,871,088
|
$5,202,000 | — | 31 Dec 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.9%
|
1,774,815
|
$4,934,000 | — | 31 Dec 2019 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.47%
|
926,200
|
$2,575,000 | — | 31 Dec 2019 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.43%
|
850,000
|
$2,363,000 | — | 31 Dec 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.36%
|
717,250
|
$1,994,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.32%
|
635,808
|
$1,768,000 | — | 31 Dec 2019 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.3%
|
600,000
|
$1,668,000 | — | 31 Dec 2019 | |
| NORGES BANK |
13F
|
Company |
0.19%
|
369,720
|
$1,028,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
295,976
|
$823,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
256,327
|
$713,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
243,218
|
$676,000 | — | 31 Dec 2019 | |
| Verition Fund Management LLC |
13F
|
Company |
0.09%
|
174,455
|
$485,000 | — | 31 Dec 2019 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.08%
|
166,138
|
$462,000 | — | 31 Dec 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.07%
|
145,210
|
$403,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
127,513
|
$354,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.05%
|
98,537
|
$274,000 | — | 31 Dec 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
90,864
|
$253,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
86,091
|
$239,000 | — | 31 Dec 2019 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
81,000
|
$225,000 | — | 31 Dec 2019 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.04%
|
77,368
|
$215,000 | — | 31 Dec 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
64,246
|
$179,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
54,993
|
$153,000 | — | 31 Dec 2019 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
44,892
|
$124,000 | — | 31 Dec 2019 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
43,344
|
$120,000 | — | 31 Dec 2019 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.02%
|
42,373
|
$118,000 | — | 31 Dec 2019 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$111,000 | — | 31 Dec 2019 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.02%
|
36,559
|
$102,000 | — | 31 Dec 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.01%
|
22,051
|
$61,000 | — | 31 Dec 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
21,261
|
$59,000 | — | 31 Dec 2019 | |
| Paloma Partners Management Co |
13F
|
Company |
0.01%
|
19,674
|
$55,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
11,686
|
$32,000 | — | 31 Dec 2019 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.01%
|
11,650
|
$32,000 | — | 31 Dec 2019 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.01%
|
10,780
|
$30,000 | — | 31 Dec 2019 | |
| Secure Asset Management, LLC |
13F
|
Company |
0.01%
|
10,000
|
$28,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
9,127
|
$25,000 | — | 31 Dec 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
5,746
|
$16,000 | — | 31 Dec 2019 | |
| Sterling Investment Advisors, Ltd. |
13F
|
Company |
0%
|
4,000
|
$11,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
3,000
|
$8,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
1,742
|
$4,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,283
|
$3,000 | — | 31 Dec 2019 | |
| HARBOR INVESTMENT ADVISORY, LLC |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 31 Dec 2019 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
895
|
$2,000 | — | 31 Dec 2019 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
800
|
$2,224 | — | 31 Dec 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
360
|
$1,000 | — | 31 Dec 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
350
|
$1,000 | — | 31 Dec 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
217
|
$1,000 | — | 31 Dec 2019 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q1 2020
As of 31 Mar 2020,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,281,827 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, Advisor Group Holdings, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Hudson Bay Capital Management LP, and PRIMECAP MANAGEMENT CO/CA/.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
51
Q1 2020 holders
44
Holder diff
-7
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.